Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Three Companies Registering Heavy Insider Buying Activity

Page 1 of 2

The insider buying activity significantly contracted last week relative to the previous one, while the volume of insider selling remained somewhat unchanged. Although statistics reveal that insiders are bearish on the market at the moment, there are corporate insiders that have recently put more faith in their companies’ future prospects. Why would anyone invest his/her hard-earned money in stock markets without expecting to generate a return on this investment? In fact, extensive research has provided evidence that insider purchases tend to greatly outperform the broader market over a relatively long-term investment spectrum. With this in mind, the following article will discuss the insider buying activity at three companies and potential reasons that might explain insiders’ ‘bullishness’.


Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned 102% over the ensuing 37 months, outperforming the S&P 500 Index by more than 53 percentage points (read the details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

FTI Consulting Inc. (NYSE:FCN) is one of the companies that registered unusual insider buying activity last week. Chief Financial Officer David M. Johnson snapped up 15,000 shares on Friday at prices ranging from $35.39 to $36.45, boosting his stake to 44,132 shares. The shares of the business advisory firm have plummeted following the release of its third-quarter earnings report at the end of October, and are down nearly 6% year-to-date. FTI Consulting Inc. (NYSE:FCN) reported earnings per share of $0.25 on revenues of $455.5 million, compared to EPS of $0.55 on revenues of $451.2 million reported a year ago. The company also cut its revenue and adjusted EPS expectations for 2015, as a result of “persistent headwinds” facing its core businesses. The stock seems to be fairly valued at the moment if bearing in mind its trailing P/E ratio of 26.73, which compares to the median of 23.41 for the S&P 500. Meanwhile, 11 hedge funds tracked by our team held positions in FTI Consulting at the end of the second quarter, stockpiling 2.70% of its outstanding common stock. Joel Greenblatt’s Gotham Asset Management owned nearly 419,000 shares in FTI Consulting Inc. (NYSE:FCN) on June 30.

The next page of the article discusses the heavy insider buying activity at Cliffs Natural Resources Inc. (NYSE:CLF) and Olin Corporation (NYSE:OLN).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!